Navigation Links
Lota Zoth Elected to Ikaria Board and Named Audit Committee Chair
Date:1/22/2008

CLINTON, N.J., Jan. 22 /PRNewswire/ -- Ikaria Holdings, Inc., a fully integrated critical care biopharmaceutical company, announced today that Lota S. Zoth has been elected as an independent member of the company's Board of Directors. Ms. Zoth, the former Chief Financial Officer of MedImmune, will chair the Ikaria Audit Committee.

"We are very fortunate to have an executive with Lota's background and qualifications joining our Board at a very important time in the company's history," said David Shaw, Chairman of the Ikaria Board of Directors. "Lota's deep understanding of financial and accounting issues, in addition to her senior leadership experience in the pharmaceutical business, make her a superb fit for Ikaria."

Ms. Zoth served as MedImmune's Chief Financial Officer from 2004 until mid 2007, when MedImmune was acquired by AstraZeneca. Prior to that, Ms. Zoth served as Chief Accounting Officer of MedImmune, PSINet and Sodexho Marriott, all publicly traded companies. Ms. Zoth began her career as an auditor with Ernst & Young, and went on to management positions in financial reporting and controllership at PepsiCo and Marriott International. Ms. Zoth is a CPA, and holds a BBA, summa cum laude, in accounting from Texas Tech University.

About Ikaria Holdings, Inc.

Ikaria Holdings, Inc. is a fully integrated biotherapeutics company focused on the development and commercialization of innovative in-hospital pharmaceutical products and drug/device combinations for the critically ill. The company's product, INOmax(R) (nitric oxide) for inhalation, is an FDA- approved drug for the treatment of hypoxic respiratory failure in term and near-term newborns. The drug also is approved by regulatory authorities and used in Canada, Europe, Australia and Latin America. In addition to marketing and selling its INOmax product, Ikaria is engaged in both Phase II trials with Covox(R) (carbon monoxide) for inhalation and Phase I trials with hydrogen sulfide (H2S) for various indications. Ikaria has a staff of over 300 people and is headquartered in Clinton, NJ, with research facilities in Seattle, WA and Madison, WI and manufacturing in Port Allen, LA. For more information on Ikaria, please visit http://www.ikaria.com.

CONTACTS

Elizabeth Larkin Jason Rando

Ikaria The Ruth Group

908-238-6645 646-536-7025

liz.larkin@ikaria.com jrando@theruthgroup.com


'/>"/>
SOURCE Ikaria Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Bruce Pasternack Elected to Codexis Board
2. Biomaxx Systems Inc. Selected as Technical Consultant By Southern Cross Agricultural Developments
3. Solazyme, Inc. Selected by AlwaysOn as a GoingGreen 100 Top Private Company Award Winner
4. Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion Project
5. AG Mednet Selected By Massachusetts General Hospital to Transport 3D Post-Processing Images
6. Medivation Selected as Founding Member of New NASDAQ(R) NeuroInsights(R) Neurotech Index
7. Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index
8. Solazyme Selected for National Institute of Standards and Technology Award
9. Advanced Life Sciences to Present Data from Selected Cethromycin Clinical Trials at the 45th Annual Meeting of the Infectious Diseases Society of America
10. Genstructs Andrea Matthews Selected for Mass High Techs People to Watch Under 30
11. Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , ... October 11, 2017 , ... ComplianceOnline’s Medical Device ... on 7th and 8th June 2018 in San Francisco, CA. The Summit brings together ... as several distinguished CEOs, board directors and government officials from around the world to ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... Disappearing forests ... the lives of over 5.5 million people each year. Especially those living in larger ... startup Treepex - based in one of the most pollution-affected countries globally - decided ...
(Date:10/10/2017)... CA (PRWEB) , ... October ... ... a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today ... of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration ...
(Date:10/10/2017)... Oct. 10, 2017 SomaGenics announced the receipt ... to develop RealSeq®-SC (Single Cell), expected to be the ... RNAs (including microRNAs) from single cells using NGS methods. ... need to accelerate development of approaches to analyze the ... "New techniques for measuring levels of mRNAs in ...
Breaking Biology Technology:
(Date:4/11/2017)... No two people are believed to ... York University Tandon School of Engineering and Michigan ... partial similarities between prints are common enough that ... and other electronic devices can be more vulnerable ... in the fact that fingerprint-based authentication systems feature ...
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC ... announced that the United States Patent and Trademark Office ... broadly covers the linking of an iris image with ... transaction) and represents the company,s 45 th issued ... patent is very timely given the multi-modal biometric capabilities ...
Breaking Biology News(10 mins):